Witte, Franziska
Ruiz-Orera, Jorge
Mattioli, Camilla Ciolli
Blachut, Susanne
Adami, Eleonora
Schulz, Jana Felicitas
Schneider-Lunitz, Valentin
Hummel, Oliver
Patone, Giannino
Mücke, Michael Benedikt
Šilhavý, Jan
Heinig, Matthias
Bottolo, Leonardo
Sanchis, Daniel
Vingron, Martin
Chekulaeva, Marina
Pravenec, Michal
Hubner, Norbert
van Heesch, Sebastiaan https://orcid.org/0000-0001-9593-1980
Funding for this research was provided by:
European Molecular Biology Organization (ALTF 186-2015 / LTFCOFUND2013, GA-2013-609409)
European Research Council (AdG788970)
Fondation Leducq (16CVD03)
Akademie Věd České Republiky (AP1502)
Fundació la Marató de TV3 (20153810)
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC)
Article History
Received: 17 July 2020
Accepted: 2 June 2021
First Online: 28 June 2021
Declarations
:
: All rat experimental procedures were carried out in accordance with the European Union National Guidelines and the Animal Protection Law of the Czech Republic (311/1997) and were approved by the Ethics Committee of the Institute of Physiology, Czech Academy of Sciences, Prague. Investigations with Endog KO mice were approved by the Experimental Animal Ethic Committee of the University of Lleida (code CEEA N02-02/15) and conform to the Guide for the Care and Use of Laboratory Animals, 8th Edition, published in 2011 by the US National Institutes of Health. All rat and mouse animals used in this study were drug and test naive, specific pathogen-free (SPF), and not involved in previous procedures.
: Not applicable.
: The authors declare that they have no competing interests.